These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12480806)

  • 1. Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases.
    Spinale FG
    Circ Res; 2002 Dec; 91(12):1082-4. PubMed ID: 12480806
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases.
    Tsuruda T; Boerrigter G; Huntley BK; Noser JA; Cataliotti A; Costello-Boerrigter LC; Chen HH; Burnett JC
    Circ Res; 2002 Dec; 91(12):1127-34. PubMed ID: 12480813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases: pathways of induction by bioactive molecules.
    Tsuruda T; Costello-Boerrigter LC; Burnett JC
    Heart Fail Rev; 2004 Jan; 9(1):53-61. PubMed ID: 14739768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast contributions to ischemic cardiac remodeling.
    Burke RM; Burgos Villar KN; Small EM
    Cell Signal; 2021 Jan; 77():109824. PubMed ID: 33144186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix matters.
    Libby P; Lee RT
    Circulation; 2000 Oct; 102(16):1874-6. PubMed ID: 11034930
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of Myocardial Extracellular Matrix Dynamic Changes in Myocardial Infarction and Postinfarct Remodeling.
    Ushakov A; Ivanchenko V; Gagarina A
    Curr Cardiol Rev; 2020; 16(1):11-24. PubMed ID: 31072294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruptions and detours in the myocardial matrix highway and heart failure.
    Deschamps AM; Spinale FG
    Curr Heart Fail Rep; 2005 Mar; 2(1):10-7. PubMed ID: 16036046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial structure and matrix metalloproteinases.
    Aggeli C; Pietri P; Felekos I; Rautopoulos L; Toutouzas K; Tsiamis E; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1113-31. PubMed ID: 22519443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathways that influence extracellular remodeling.
    Lee RT; Lammerding J
    J Card Fail; 2002 Dec; 8(6 Suppl):S339-43. PubMed ID: 12555142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation.
    Garczorz W; Gallego-Colon E; Kosowska A; Kłych-Ratuszny A; Woźniak M; Marcol W; Niesner KJ; Francuz T
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29283509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA inhibits angiotensin II induced extracellular matrix remodeling in human cardiac fibroblasts--Implications for treatment of pathologic cardiac remodeling.
    Mao S; Li W; Qa'aty N; Vincent M; Zhang M; Hinek A
    Int J Cardiol; 2016 Jan; 202():110-7. PubMed ID: 26408838
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial proteases and cardiac remodeling.
    Riaz S; Zeidan A; Mraiche F
    J Cell Physiol; 2017 Dec; 232(12):3244-3250. PubMed ID: 28255990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.
    Siwik DA; Chang DL; Colucci WS
    Circ Res; 2000 Jun; 86(12):1259-65. PubMed ID: 10864917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH suppresses TGF-beta-mediated fibrosis and retains cardiac diastolic function.
    Imanishi R; Ashizawa N; Ohtsuru A; Seto S; Akiyama-Uchida Y; Kawano H; Kuroda H; Nakashima M; Saenko VA; Yamashita S; Yano K
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):137-46. PubMed ID: 15130518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invited for debate: is there a virus-specific matrix destruction in the course of disease in dilated cardiomyopathy?
    Waagstein F
    Ernst Schering Res Found Workshop; 2006; (55):251-7. PubMed ID: 16329666
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor necrosis factor alpha and myocardial matrix metalloproteinases in left ventricular remodeling].
    Wang XM; Yang LX; Zhu SJ; Yang YJ; Guo CM; Qi F; Wei L; Shi YK; Wang Y; Ren L
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):828-31. PubMed ID: 15634542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
    Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.